Company Orletto Capital Inc Toronto S.E.

OLEp

CA6866681043

Pharmaceuticals

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sector Other Pharmaceuticals

Inactive Instrument

End-of-day quote Toronto S.E. Other stock markets
-	-

06-25	Devonian Health Group Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2024	CI
06-03	Devonian Health Group Founder Assumes Chair, COO Roles	MT

Devonian Health Group Inc. is a Canada-based late-stage botanical pharmaceutical company. The Company's main activity is the development of botanical drugs from plant materials and algae for the treatment of inflammatory-autoimmune diseases, including ulcerative colitis and atopic dermatitis. It is also involved in the development of value-added products for dermo-cosmetics and the distribution of pharmaceutical products through its subsidiary. The Companyâs flagship product, Thykamine, the pharmaceutical product issued from its SUPREX platform, is a product for the prevention and treatment of health conditions related to inflammation and oxidative stress. The Companyâs flagship product, Thykamine, the pharmaceutical product issued from its SUPREX platform, is a product for the prevention and treatment of health conditions related to inflammation and oxidative stress. The Company's cosmeceutical products include R-Spinasome and Purgenesis.

CAD in Million	2024	Weight	Delta
Pharmaceutical 100.0 %	2	100.0 %	-

CAD in Million	2024	Weight	Delta
Canada 100.0 %	2	100.0 %	-

Managers	Title	Age	Since
Luc Grégoire CEO	Chief Executive Officer	64	16/03/23
André Boulet FOU	Founder	-	26/03/15
Colette Laurin DFI	Director of Finance/CFO	-	27/12/15
Pascal Brabant CTO	Chief Tech/Sci/R&D Officer	-	-
Daniel Bouthillier CTO	Chief Tech/Sci/R&D Officer	-	-
Nathalie Boucher PRN	Corporate Officer/Principal	-	-

Members of the board	Title	Age	Since
André Boulet FOU	Founder	-	26/03/15
Luc Grégoire CEO	Chief Executive Officer	64	16/03/23
Kathryn Gregory BRD	Director/Board Member	62	02-27
Jean Forcione BRD	Director/Board Member	58	11/05/23
Louis Flamand BRD	Director/Board Member	-	24/05/17
Edouard Dahl BRD	Director/Board Member	-	11/05/23

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	148,222,532	127,172,676 ( 85.80 %)	0	85.80 %

Name	Equities	%	Valuation
André Boulet 13.55 %	20,083,189	13.55 %	4 M
Jean Forcione 0.4498 %	666,667	0.4498 %	145 333
Pierre Montanaro 0.2024 %	299,999	0.2024 %	65 400
Richard Provencher 0.1022 %	151,486	0.1022 %	33 024
Colette Laurin 0.0225 %	33,333	0.0225 %	7 267
Terry Fretz 0.0107 %	15,866	0.0107 %	3 459
Luc Grégoire 0.000000 %	0	0.000000 %	-
Kathryn Gregory 0.000000 %	0	0.000000 %	-
David Baker 0.000000 %	0	0.000000 %	-
Ashish Chabria 0.000000 %	0	0.000000 %	-

Devonian Health Group, Inc.

360, rue des Entrepreneurs

G5V 4T1, Montmagny

http://www.groupedevonian.com

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Other Pharmaceuticals

	1st Jan change	Capi.
ELI LILLY AND COMPANY	+61.53%	856B
NOVO NORDISK A/S	+38.95%	631B
JOHNSON & JOHNSON	-3.66%	359B
MERCK & CO., INC.	+15.06%	325B
ABBVIE INC.	+9.18%	297B
ROCHE HOLDING AG	+5.89%	234B
NOVARTIS AG	+16.53%	226B
AMGEN INC.	+15.67%	177B
PFIZER, INC.	+2.47%	165B

Other Pharmaceuticals